GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma

Clinical trial NCT05668884 · RECRUITING

Trial details

NCT number: NCT05668884
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Carcinoma

Start date: 2022-10-18
Primary completion: 2026-12-31
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.